Castlight Health (CSLT) Reports In-Line Q3 EPS, Offers Guidance

Go back to Castlight Health (CSLT) Reports In-Line Q3 EPS, Offers Guidance

Leerink Partners Downgrades Castlight Health Inc. (CSLT) to Market Perform

November 5, 2015 7:30 AM EST

Leerink Partners downgraded Castlight Health Inc. (NYSE: CSLT) from Outperform to Market Perform with a price target of $5.00 (from $14.00).

Analyst Steven Wardell commented, "On its Wed. night earnings call, Castlight announced unexpected issues with its sales cycle and provided a first look at its 2016... More